Page last updated: 2024-08-21

pyrazines and Anemia, Hemolytic

pyrazines has been researched along with Anemia, Hemolytic in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Wang, Y; Zhang, Z; Zhou, W	1
Birgens, H; Brown, Pde N; Dalseg, AM; Dufva, IH; Hasselbalch, HC; Jensen, MK; Vangsted, A	1
Dasanu, CA	1
Mehta, N; Niesvizky, R; Saxena, A	1

Reviews

1 review(s) available for pyrazines and Anemia, Hemolytic

Article	Year
[Novel medical treatment modalities in hematology]. Ugeskrift for laeger, 2008, Jun-09, Volume: 170, Issue:24 Topics: Aminoglycosides; Anemia, Hemolytic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Benzamides; Benzoates; Boronic Acids; Bortezomib; Carbazoles; Carrier Proteins; Cyclophosphamide; Dasatinib; Furans; Gemtuzumab; Hematologic Diseases; Humans; Hydrazines; Imatinib Mesylate; Immunologic Factors; Indoles; Lenalidomide; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes; Piperazines; Purpura, Thrombocytopenic; Pyrazines; Pyrazoles; Pyrimidines; Receptors, Fc; Recombinant Fusion Proteins; Rituximab; Thalidomide; Thiazoles; Thrombopoietin; Vidarabine	2008

Article

Year

[Novel medical treatment modalities in hematology].

Ugeskrift for laeger, 2008, Jun-09, Volume: 170, Issue:24

Topics: Aminoglycosides; Anemia, Hemolytic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Benzamides; Benzoates; Boronic Acids; Bortezomib; Carbazoles; Carrier Proteins; Cyclophosphamide; Dasatinib; Furans; Gemtuzumab; Hematologic Diseases; Humans; Hydrazines; Imatinib Mesylate; Immunologic Factors; Indoles; Lenalidomide; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes; Piperazines; Purpura, Thrombocytopenic; Pyrazines; Pyrazoles; Pyrimidines; Receptors, Fc; Recombinant Fusion Proteins; Rituximab; Thalidomide; Thiazoles; Thrombopoietin; Vidarabine

2008

Other Studies

3 other study(ies) available for pyrazines and Anemia, Hemolytic

Article	Year
Successful treatment of warm-type haemolytic anaemia with bortezomib in a rituximab-failed systemic lupus erythematosus patient. Rheumatology (Oxford, England), 2015, Volume: 54, Issue:1 Topics: Aged; Anemia, Hemolytic; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Boronic Acids; Bortezomib; Comorbidity; Female; Humans; Lupus Erythematosus, Systemic; Proteasome Inhibitors; Pyrazines; Rituximab; Treatment Failure; Treatment Outcome	2015
Bortezomib: friend or foe of hemolytic anemia? Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2011, Volume: 17, Issue:3 Topics: Anemia, Hemolytic; Animals; Autoimmune Diseases; Boronic Acids; Bortezomib; Evidence-Based Medicine; Humans; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Risk Assessment; Risk Factors	2011
Bortezomib-induced thrombotic thrombocytopaenic purpura. BMJ case reports, 2012, Aug-01, Volume: 2012 Topics: Aged; Anemia, Hemolytic; Antineoplastic Agents; Boronic Acids; Bortezomib; Confusion; Female; Humans; Multiple Myeloma; Plasma Exchange; Plasmapheresis; Platelet Count; Prognosis; Purpura, Thrombotic Thrombocytopenic; Pyrazines; Severity of Illness Index; Treatment Outcome	2012